Evaluationof 161Tb-Labeled DOTA-Ibandronatefor Targeted Radionuclide Therapy in Bone Metastases

MOLECULAR PHARMACEUTICS · Published 2026-07-14 · DOI 10.1021/acs.molpharmaceut.5c01869

Authors (11)

Chunfang Zhang, Yingwei Wang, Jia Deng, Die You, Ya Liu, Lei Lei, Yan Zhao, Jian Yang, Li Wang, Wei Wang, Yue Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhang, C., Wang, Y., Deng, J., et al. (2026). Evaluationof 161Tb-Labeled DOTA-Ibandronatefor Targeted Radionuclide Therapy in Bone Metastases. MOLECULAR PHARMACEUTICS. https://doi.org/10.1021/acs.molpharmaceut.5c01869

Related articles